search
Back to results

Myocardial Infarction - Stress Prevention Intervention (MI-SPRINT)

Primary Purpose

Stress Disorders, Post-Traumatic, Myocardial Infarction

Status
Terminated
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Minimal behavioral intervention
Control intervention
Sponsored by
Insel Gruppe AG, University Hospital Bern
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Stress Disorders, Post-Traumatic focused on measuring Stress Disorders, Post-Traumatic, Myocardial Infarction, Psychotherapy, Preventive Therapy, Randomized Controlled Trial, Cardiovascular Diseases, Psychological Stress, Biomarkers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age over 18 years
  • STEMI (ST-elevated myocardial infarction) or non-STEMI
  • Stable circulatory condition
  • Numeric Rating Scale (NRS) (0-10): a score of at least 5 for "pain (during MI)" plus a score of at least 5 for "fear of dying (until admission to the CCU)" and/or "making sorrows and feeling helpless (when being told about having MI)"
  • Written informed consent

Exclusion Criteria

  • Participating in any other randomized-controlled trial run by the Cardiology Department of the University Hospital of Bern
  • Emergency coronary artery bypass graft surgery
  • Comorbid serious disease likely to cause death within 1 year
  • Current clinically severe depression
  • Not fully oriented to the situation, person, and place
  • Cognitive impairment according to an adapted short version of the Mini-Mental State Examination
  • Insufficient knowledge of German language in reading and understanding
  • Affirmation of suicidal ideation in the last two weeks

Sites / Locations

  • Dep. of General Internal Medicine, Bern University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control group

Arm Description

Patients in the intervention group will participate in one single counseling session of 45 minutes (the minimal behavioral intervention) that targets specific MI-triggered traumatic reactions.

Patients in the control group will participate in one single counseling session of 45 minutes (the control intervention) that targets more general information about the role of psychological stress in coronary heart disease.

Outcomes

Primary Outcome Measures

Clinician-rated posttraumatic stress level
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)

Secondary Outcome Measures

Clinician-rated posttraumatic stress level
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)
Self-rated Posttraumatic Stress
Measured by Posttraumatic Diagnostic Scale (PDS) (German version); The term "event" will be replaced with the term "heart attack" to assess MI-specific posttraumatic stress.
Quality of Life
Measured by EuroQol group 5 dimension questionnaire (EQ-5D) (German version)
Depressive Symptoms
Measured by Beck Depression Inventory (BDI) (German version)
Overall psychological distress
Measured by self-rated symptom checklist-9 (SCL-9-K) (German version)
Positive and Negative Affect
Measured by 20-item Global Mood Scale (GMS) (German version)
Time duration to recurrence at previous job (incl. part-time)
Time duration to recurrence at household to extent at least 50%
Vitality status
Measured if alive or deceased (with cause of death)
Recurrent Hospitalisations
Measured: number and cause
Recurrent Doctor Visits - general practitioner as well as specialist
Measured: number and cause
Inflammation Markers
Measured by high sensitive C-reactive protein, Interleukin-6, Tumor necrosis factor alpha, Interleukin-4
Hemostasis Markers
Measured by Fibrinogen, D-dimer, von Willebrand factor (antigen)
Metabolic Factors
Measured by total cholesterol, Low-density lipoprotein-Cholesterol, High-density lipoprotein-Cholesterol, triglycerides, glucose, HbA1c
Anthropometric measurements
Measured by weight, height, body mass index (kg/m2), waist circumference, hip circumference, waist-to-hip ratio
Resting hemodynamics
Measured by heart rate, systolic blood pressure, diastolic blood pressure
Heart rate variability
Measured by total power, high frequency power, low frequency power, low-to-high frequency power ratio
Stress Hormones
Measured by plasma cortisol, norepinephrine, epinephrine

Full Information

First Posted
January 21, 2013
Last Updated
January 6, 2016
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
Swiss National Science Foundation, University of Bern, University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT01781247
Brief Title
Myocardial Infarction - Stress Prevention Intervention
Acronym
MI-SPRINT
Official Title
MI-SPRINT (Myocardial Infarction - Stress PRevention INTervention): A Randomized Controlled Minimal Early Behavioral Intervention Trial to Reduce the Development of Posttraumatic Stress Caused by Acute Myocardial Infarction
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Terminated
Why Stopped
Population of eligible patients smaller than anticipated
Study Start Date
January 2013 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
Swiss National Science Foundation, University of Bern, University of Zurich

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Posttraumatic Stress Disorder (PTSD) is a mental disorder that may occur after someone experiences a traumatic event. Between 10-20% of patients may develop PTSD in response to the traumatic experience of myocardial infarction (MI). PTSD is associated with impaired quality of life, social functioning, and high economic burden to the society. Posttraumatic stress attributable to MI has also been shown to be predictive of poor cardiovascular prognosis, whereby this link might relate to several atherothrombotic processes. Therefore the prevention of PTSD after MI is of high relevance. Guidelines have been published for early interventions to prevent the development of posttraumatic stress after different types of trauma but not in terms of acute MI as a traumatic event. The overarching aim of the planned trial is to test whether a minimal behavioral intervention performed shortly after acute MI in patients at a high risk to develop PTSD and in the setting of a coronary care unit reduces the development of posttraumatic stress. The primary hypothesis is that posttraumatic stress levels at the 3-month follow-up will be at least 20% lower in the intervention group than in the control group, and that this effect will last up to 12 months after the intervention. The secondary hypothesis is that the intervention group will show better psychosocial functioning, and a more favourable cardiometabolic biomarker profile than the control group 3 and 12 month after the intervention.
Detailed Description
Background Posttraumatic Stress Disorder (PTSD) is a mental disorder that may occur after someone experiences a traumatic event. Between 10-20% of patients may develop PTSD in response to the traumatic experience of myocardial infarction (MI). Sociodemographic and psychosocial variables, including perceived distress during MI, have been identified as "risk factors" for the development of posttraumatic stress in the aftermath of MI. PTSD is associated with impaired quality of life, social functioning, and high economic burden to the society. Posttraumatic stress attributable to MI has also been shown to be predictive of poor cardiovascular prognosis, whereby this link might relate to atherothrombotic processes like endothelial dysfunction, dyslipidemia, inflammation, and coagulation. Therefore the prevention of PTSD after MI is of high relevance. Guidelines have been published for early interventions to prevent the development of posttraumatic stress after different types of trauma. A recent systematic review and meta-analysis on randomized controlled trials of early psychological interventions designed to prevent symptoms of PTSD found a benefit, but only if treatment was provided to symptomatic individuals and trauma-focused. The impact of such an intervention on posttraumatic stress in response to a myocardial infarction has not been assessed so far. The planned project is the first to test, if the development of posttraumatic stress can successfully be prevented in MI patients at high risk to develop PTSD through a minimal behavioral intervention that is feasible. Objective Primary aim: The overarching aim of the planned project is to investigate in a randomized-controlled trial whether a minimal (single counseling session of 45 minutes plus an information booklet) and early-on (within 48 hours after myocardial infarction) administered behavioral intervention reduces the development of clinician-rated posttraumatic stress levels attributable to MI in patients at a high risk to develop clinically relevant levels of posttraumatic stress. Secondary aim: A further aim is to investigate whether the behavioral intervention improves psychosocial functioning and favorably affects cardiometabolic risk markers. Methods Patients considered to be at "high risk" to develop posttraumatic stress will be randomized to one single counseling session of 45 minutes (either targeting specific MI-triggered traumatic reactions or more general information about the role of psychological stress in coronary heart disease). The session will be performed by the study therapist in the coronary care unit within 48 hours after the patient has reached stable circulatory condition. Each patient will additionally receive written study material in the form of an information booklet. Medical variables, sociodemographic factors and cardiometabolic biomarkers will also be determined. At 3-month and 12-month follow-up each patient will be assessed for interviewer-rated posttraumatic stress levels, psychosocial functioning, and biomarkers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress Disorders, Post-Traumatic, Myocardial Infarction
Keywords
Stress Disorders, Post-Traumatic, Myocardial Infarction, Psychotherapy, Preventive Therapy, Randomized Controlled Trial, Cardiovascular Diseases, Psychological Stress, Biomarkers

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
190 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Patients in the intervention group will participate in one single counseling session of 45 minutes (the minimal behavioral intervention) that targets specific MI-triggered traumatic reactions.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Patients in the control group will participate in one single counseling session of 45 minutes (the control intervention) that targets more general information about the role of psychological stress in coronary heart disease.
Intervention Type
Behavioral
Intervention Name(s)
Minimal behavioral intervention
Intervention Description
The minimal behavioral intervention consists of one single counseling session of 45 minutes that targets specific MI-triggered traumatic reactions. The focus of the intervention is an educational and resource-oriented approach targeting individual patient resources and cognitive (re)structuring.
Intervention Type
Behavioral
Intervention Name(s)
Control intervention
Intervention Description
The control intervention consists of one single counseling session of 45 minutes that targets more general information about the role of psychological stress in coronary heart disease. Any terminology related to "trauma" will be completely avoided.
Primary Outcome Measure Information:
Title
Clinician-rated posttraumatic stress level
Description
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Clinician-rated posttraumatic stress level
Description
Measured by Clinician-Administered PTSD Scale (CAPS) (German version)
Time Frame
12 months
Title
Self-rated Posttraumatic Stress
Description
Measured by Posttraumatic Diagnostic Scale (PDS) (German version); The term "event" will be replaced with the term "heart attack" to assess MI-specific posttraumatic stress.
Time Frame
3 and 12 months
Title
Quality of Life
Description
Measured by EuroQol group 5 dimension questionnaire (EQ-5D) (German version)
Time Frame
3 and 12 months
Title
Depressive Symptoms
Description
Measured by Beck Depression Inventory (BDI) (German version)
Time Frame
3 and 12 months
Title
Overall psychological distress
Description
Measured by self-rated symptom checklist-9 (SCL-9-K) (German version)
Time Frame
3 and 12 months
Title
Positive and Negative Affect
Description
Measured by 20-item Global Mood Scale (GMS) (German version)
Time Frame
3 and 12 months
Title
Time duration to recurrence at previous job (incl. part-time)
Time Frame
3 and 12 months
Title
Time duration to recurrence at household to extent at least 50%
Time Frame
3 and 12 months
Title
Vitality status
Description
Measured if alive or deceased (with cause of death)
Time Frame
3 and 12 months
Title
Recurrent Hospitalisations
Description
Measured: number and cause
Time Frame
3 and 12 months
Title
Recurrent Doctor Visits - general practitioner as well as specialist
Description
Measured: number and cause
Time Frame
3 and 12 months
Title
Inflammation Markers
Description
Measured by high sensitive C-reactive protein, Interleukin-6, Tumor necrosis factor alpha, Interleukin-4
Time Frame
3 and 12 months
Title
Hemostasis Markers
Description
Measured by Fibrinogen, D-dimer, von Willebrand factor (antigen)
Time Frame
3 and 12 months
Title
Metabolic Factors
Description
Measured by total cholesterol, Low-density lipoprotein-Cholesterol, High-density lipoprotein-Cholesterol, triglycerides, glucose, HbA1c
Time Frame
3 and 12 months
Title
Anthropometric measurements
Description
Measured by weight, height, body mass index (kg/m2), waist circumference, hip circumference, waist-to-hip ratio
Time Frame
3 and 12 months
Title
Resting hemodynamics
Description
Measured by heart rate, systolic blood pressure, diastolic blood pressure
Time Frame
3 and 12 months
Title
Heart rate variability
Description
Measured by total power, high frequency power, low frequency power, low-to-high frequency power ratio
Time Frame
3 and 12 months
Title
Stress Hormones
Description
Measured by plasma cortisol, norepinephrine, epinephrine
Time Frame
3 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age over 18 years STEMI (ST-elevated myocardial infarction) or non-STEMI Stable circulatory condition Numeric Rating Scale (NRS) (0-10): a score of at least 5 for "pain (during MI)" plus a score of at least 5 for "fear of dying (until admission to the CCU)" and/or "making sorrows and feeling helpless (when being told about having MI)" Written informed consent Exclusion Criteria Participating in any other randomized-controlled trial run by the Cardiology Department of the University Hospital of Bern Emergency coronary artery bypass graft surgery Comorbid serious disease likely to cause death within 1 year Current clinically severe depression Not fully oriented to the situation, person, and place Cognitive impairment according to an adapted short version of the Mini-Mental State Examination Insufficient knowledge of German language in reading and understanding Affirmation of suicidal ideation in the last two weeks
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roland von Känel, Prof. Dr. med.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jean-Paul Schmid, PD Dr. med.
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ulrich Schnyder, Prof. Dr. med.
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Hansjörg Znoj, Prof. Dr. phil.
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jürgen Barth, PD Dr. phil.
Official's Role
Study Chair
Facility Information:
Facility Name
Dep. of General Internal Medicine, Bern University Hospital
City
Bern
ZIP/Postal Code
3010
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
16575268
Citation
Gander ML, von Kanel R. Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):165-72. doi: 10.1097/01.hjr.0000214606.60995.46.
Results Reference
background
PubMed Identifier
22745687
Citation
Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS One. 2012;7(6):e38915. doi: 10.1371/journal.pone.0038915. Epub 2012 Jun 20. Erratum In: PLoS One. 2019 Mar 6;14(3):e0213635.
Results Reference
background
PubMed Identifier
21493042
Citation
von Kanel R, Hari R, Schmid JP, Wiedemar L, Guler E, Barth J, Saner H, Schnyder U, Begre S. Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol. 2011 Jul;58(1):61-8. doi: 10.1016/j.jjcc.2011.02.007. Epub 2011 Apr 13.
Results Reference
background
PubMed Identifier
19188285
Citation
Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI. Systematic review and meta-analysis of multiple-session early interventions following traumatic events. Am J Psychiatry. 2009 Mar;166(3):293-301. doi: 10.1176/appi.ajp.2008.08040590. Epub 2009 Feb 2.
Results Reference
background
PubMed Identifier
14557148
Citation
Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M, Herbert C, Mayou R. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 Oct;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024.
Results Reference
background
PubMed Identifier
35498017
Citation
von Kanel R, Meister-Langraf RE, Zuccarella-Hackl C, Znoj H, Pazhenkottil AP, Schmid JP, Barth J, Schnyder U, Princip M. Association Between Changes in Post-hospital Cardiac Symptoms and Changes in Acute Coronary Syndrome-Induced Symptoms of Post-traumatic Stress. Front Cardiovasc Med. 2022 Apr 14;9:852710. doi: 10.3389/fcvm.2022.852710. eCollection 2022.
Results Reference
derived
PubMed Identifier
33580657
Citation
von Kanel R, Meister-Langraf RE, Pazhenkottil AP, Barth J, Schnyder U, Schmid JP, Znoj H, Princip M. Insomnia Symptoms and Acute Coronary Syndrome-Induced Posttraumatic Stress Symptoms: A Comprehensive Analysis of Cross-sectional and Prospective Associations. Ann Behav Med. 2021 Oct 4;55(10):1019-1030. doi: 10.1093/abm/kaaa128.
Results Reference
derived
PubMed Identifier
33432839
Citation
von Kanel R, Schmid JP, Meister-Langraf RE, Barth J, Znoj H, Schnyder U, Princip M, Pazhenkottil AP. Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder. J Am Heart Assoc. 2021 Jan 19;10(2):e018762. doi: 10.1161/JAHA.120.018762. Epub 2021 Jan 12.
Results Reference
derived
PubMed Identifier
30463526
Citation
von Kanel R, Princip M, Schmid JP, Barth J, Znoj H, Schnyder U, Meister-Langraf RE. Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction. BMC Cardiovasc Disord. 2018 Nov 21;18(1):213. doi: 10.1186/s12872-018-0947-5.
Results Reference
derived
PubMed Identifier
24119487
Citation
Meister R, Princip M, Schmid JP, Schnyder U, Barth J, Znoj H, Herbert C, von Kanel R. Myocardial Infarction - Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: study protocol for a randomized controlled trial. Trials. 2013 Oct 11;14:329. doi: 10.1186/1745-6215-14-329.
Results Reference
derived

Learn more about this trial

Myocardial Infarction - Stress Prevention Intervention

We'll reach out to this number within 24 hrs